Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)

被引:28
|
作者
Rossello, Xavier [1 ,2 ]
Dorresteijn, Jannick A. N. [3 ]
Janssen, Arne [4 ]
Lambrinou, Ekaterini [4 ,5 ]
Scherrenberg, Martijn [6 ,7 ]
Bonnefoy-Cudraz, Eric [8 ]
Cobain, Mark [9 ]
Piepoli, Massimo F. [10 ,11 ]
Visseren, Frank L. J. [2 ]
Dendale, Paul [6 ,7 ]
机构
[1] CNIC, Madrid, Spain
[2] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain
[3] Univ Med Ctr Utrecht, Dept Vasc Med, Utrecht, Netherlands
[4] Jessa Hosp, Heartctr Hasselt, Clin Res Dept Cardiol, Hasselt, Belgium
[5] Cyprus Univ Technol, Dept Nursing, Limassol, Cyprus
[6] Jessa Hosp, Heartctr Hasselt, Hasselt, Belgium
[7] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium
[8] Hop Cardiol Lyon, Dept Cardiol, Lyon, France
[9] Imperial Coll, Dept Cardiovasc Med, London, England
[10] Guglielmo da Saliceto Hosp, Heart Failure Unit, Cardiol, Piacenza, Italy
[11] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
关键词
Risk prediction; risk assessment; cardiovascular disease; prevention; patient; ACUTE HEART-FAILURE; SECONDARY PREVENTION; VASCULAR-DISEASE; DECISION-MAKING; VALIDATION; MODEL; SCORE; METAANALYSIS; MORTALITY; SURVIVAL;
D O I
10.1177/1474515119856207
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Risk assessment have become essential in the prevention of cardiovascular disease. Even though risk prediction tools are recommended in the European guidelines, they are not adequately implemented in clinical practice. Risk prediction tools are meant to estimate prognosis in an unbiased and reliable way and to provide objective information on outcome probabilities. They support informed treatment decisions about the initiation or adjustment of preventive medication. Risk prediction tools facilitate risk communication to the patient and their family, and this may increase commitment and motivation to improve their health. Over the years many risk algorithms have been developed to predict 10-year cardiovascular mortality or lifetime risk in different populations, such as in healthy individuals, patients with established cardiovascular disease and patients with diabetes mellitus. Each risk algorithm has its own limitations, so different algorithms should be used in different patient populations. Risk algorithms are made available for use in clinical practice by means of - usually interactive and online available - tools. To help the clinician to choose the right tool for the right patient, a summary of available tools is provided. When choosing a tool, physicians should consider medical history, geographical region, clinical guidelines and additional risk measures among other things. Currently, the U-prevent.com website is the only risk prediction tool providing prediction algorithms for all patient categories, and its implementation in clinical practice is suggested/advised by the European Association of Preventive Cardiology.
引用
收藏
页码:534 / 544
页数:11
相关论文
共 34 条
  • [21] Transcatheter interventions for left-sided valvular heart disease complicated by cardiogenic shock: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the Association for Acute Cardiovascular Care (ACVC) and the ESC Working Group on Cardiovascular Surgery
    Fraccaro, Chiara
    Karam, Nicole
    Moellmann, Helge
    Bleiziffer, Sabine
    Bonaros, Nikolaos
    Teles, Rui Campante
    Ferreira, Pedro Carrilho
    Chieffo, Alaide
    Czerny, Martin
    Donal, Erwan
    Dudek, Dariusz
    Dumonteil, Nicolas
    Esposito, Giovanni
    Fournier, Stephane
    Hassager, Christian
    Kim, Won-Keun
    Krychtiuk, Konstantin A.
    Mehilli, Julinda
    Pregowski, Jerzy
    Stefanini, Giulio G.
    Ternacle, Julien
    Thiele, Holger
    Thielmann, Matthias
    Vincent, Flavien
    Bardeleben, Ralph Stephan von
    Tarantini, Giuseppe
    EUROINTERVENTION, 2023, 19 (08) : 634 - +
  • [22] How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology
    Pedretti, Roberto F. E.
    Hansen, Dominique
    Ambrosetti, Marco
    Back, Maria
    Berger, Thomas
    Ferreira, Mariana Cordeiro
    Cornelissen, Veronique
    Davos, Constantinos H.
    Doehner, Wolfram
    Zarzosa, Carmen de Pablo Y.
    Frederix, Ines
    Greco, Andrea
    Kurpas, Donata
    Michal, Matthias
    Osto, Elena
    Pedersen, Susanne
    Salvador, Rita Esmeralda
    Simonenko, Maria
    Steca, Patrizia
    Thompson, David R.
    Wilhelm, Matthias
    Abreu, Ana
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (02) : 149 - 166
  • [23] Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology
    Ambrosetti, Marco
    Abreu, Ana
    Corra, Ugo
    Davos, Constantinos H.
    Hansen, Dominique
    Frederix, Ines
    Iliou, Marie C.
    Pedretti, Roberto F. E.
    Schmid, Jean-Paul
    Vigorito, Carlo
    Voller, Heinz
    Wilhelm, Mathias
    Piepoli, Massimo F.
    Bjarnason-Wehrens, Birna
    Berger, Thomas
    Cohen-Solal, Alain
    Cornelissen, Veronique
    Dendale, Paul
    Doehner, Wolfram
    Gaita, Dan
    Gevaert, Andreas B.
    Kemps, Hareld
    Kraenkel, Nicolle
    Laukkanen, Jari
    Mendes, Miguel
    Niebauer, Josef
    Simonenko, Maria
    Zwisler, Ann-Dorthe Olsen
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (05) : 460 - 495
  • [24] The role of exercise training on cardiovascular risk factors and heart disease in patients with chronic kidney disease G3-G5 and G5D: a Clinical Consensus Statement of the European Association of Preventive Cardiology of the ESC and the European Association of Rehabilitation in Chronic Kidney Disease
    Kouidi, Evangelia
    Hanssen, Henner
    Anding-Rost, Kirsten
    Cupisti, Adamasco
    Deligiannis, Asterios
    Grupp, Clemens
    Koufaki, Pelagia
    Leeson, Paul
    Segura-Orti, Eva
    Van Craenenbroeck, Amaryllis
    Van Craenenbroeck, Emeline
    Clyne, Naomi
    Halle, Martin
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (12) : 1493 - 1515
  • [25] Omega-6 Fatty Acids and Risk for Cardiovascular Disease A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention
    Harris, William S.
    Mozaffarian, Dariush
    Rimm, Eric
    Kris-Etherton, Penny
    Rudel, Lawrence L.
    Appel, Lawrence J.
    Engler, Marguerite M.
    Engler, Mary B.
    Sacks, Frank
    CIRCULATION, 2009, 119 (06) : 902 - 907
  • [26] AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update A Guideline From the American Heart Association and American College of Cardiology Foundation Endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association
    Smith, Sidney C., Jr.
    Benjamin, Emelia J.
    Bonow, Robert O.
    Braun, Lynne T.
    Creager, Mark A.
    Franklin, Barry A.
    Gibbons, Raymond J.
    Grundy, Scott M.
    Hiratzka, Loren F.
    Jones, Daniel W.
    Lloyd-Jones, Donald M.
    Minissian, Margo
    Mosca, Lori
    Peterson, Eric D.
    Sacco, Ralph L.
    Spertus, John
    Stein, James H.
    Taubert, Kathryn A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (23) : 2432 - 2446
  • [27] Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society
    Gorog, Diana A.
    Gue, Ying X.
    Chao, Tze-Fan
    Fauchier, Laurent
    Ferreiro, Jose Luis
    Huber, Kurt
    Konstantinidis, Stavros, V
    Lane, Deirdre A.
    Marin, Francisco
    Oldgren, Jonas
    Potpara, Tatjana
    Roldan, Vanessa
    Rubboli, Andrea
    Sibbing, Dirk
    Tse, Hung-Fat
    Vilahur, Gemma
    Lip, Gregory Y. H.
    EUROPACE, 2022, 24 (11): : 1844 - 1871
  • [28] Cardiovascular risk reduction in high-risk pediatric patients - A scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research
    Kavey, Rae-Ellen W.
    Allada, Vivek
    Daniels, Stephen R.
    Hayman, Laura L.
    McCrindle, Brian W.
    Newburger, Jane W.
    Parekh, Rulan S.
    Steinberger, Julia
    CIRCULATION, 2006, 114 (24) : 2710 - 2738
  • [29] Cardiac rehabilitation and secondary prevention of coronary heart disease - An American Heart Association Scientific Statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation
    Leon, AS
    Franklin, BA
    Costa, F
    Balady, GJ
    Berra, KA
    Stewart, KJ
    Thompson, PD
    Williams, MA
    Lauer, MS
    CIRCULATION, 2005, 111 (03) : 369 - 376
  • [30] Recommendations and Associated Levels of Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: A Comparison at Population Level of the American Heart Association/American College of Cardiology/Multisociety, US Preventive Services Task Force, Department of Veterans Affairs/Department of Defense, Canadian Cardiovascular Society, and European Society of Cardiology/European Atherosclerosis Society Clinical Practice Guidelines
    Pavlovic, Jelena
    Greenland, Philip
    Franco, Oscar H.
    Kavousi, Maryam
    Ikram, M. Kamran
    Deckers, Jaap W.
    Ikram, M. Arfan
    Leening, Maarten J. G.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (09): : E007183